JANX
Janux Therapeutics Inc

1,657
Mkt Cap
$832.06M
Volume
1.08M
52W High
$35.34
52W Low
$12.12
PE Ratio
-7.41
JANX Fundamentals
Price
$13.58
Prev Close
$13.95
Open
$14.06
50D MA
$13.70
Beta
1.47
Avg. Volume
1.14M
EPS (Annual)
-$1.83
P/B
0.86
Rev/Employee
$91,743.12
$89.28
Loading...
Loading...

About

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
109

Frequently Asked Questions

What is Market Cap of Janux Therapeutics Inc?
What is the 52-week high for Janux Therapeutics Inc?
What is the 52-week low for Janux Therapeutics Inc?
What is Janux Therapeutics Inc stock price today?
What was Janux Therapeutics Inc stock price yesterday?
What is the PE ratio of Janux Therapeutics Inc?
What is the Price-to-Book ratio of Janux Therapeutics Inc?
What is the 50-day moving average of Janux Therapeutics Inc?
How many employees does Janux Therapeutics Inc have?

Latest JANX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.